PRELUDE THERAPEUTICS INC's ticker is PRLD and the CUSIP is 74065P101. A total of 56 filers reported holding PRELUDE THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 2.40 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $578,476 | -30.1% | 187,209 | +1.8% | 0.00% | – |
| Q2 2023 | $827,141 | +230.6% | 183,809 | +318.8% | 0.00% | – |
| Q1 2023 | $250,167 | -52.8% | 43,889 | -50.0% | 0.00% | – |
| Q4 2022 | $530,180 | +82.8% | 87,778 | +100.0% | 0.00% | – |
| Q3 2022 | $290,000 | +26.6% | 43,889 | 0.0% | 0.00% | – |
| Q2 2022 | $229,000 | -84.2% | 43,889 | -79.1% | 0.00% | – |
| Q1 2022 | $1,448,000 | -44.2% | 209,861 | +0.7% | 0.00% | – |
| Q4 2021 | $2,595,000 | -90.2% | 208,406 | -75.5% | 0.00% | -100.0% |
| Q3 2021 | $26,578,000 | -11.8% | 850,483 | -19.2% | 0.00% | -50.0% |
| Q2 2021 | $30,125,000 | -20.4% | 1,052,216 | +20.5% | 0.00% | 0.0% |
| Q1 2021 | $37,843,000 | +271.6% | 873,376 | +513.6% | 0.00% | +100.0% |
| Q4 2020 | $10,184,000 | – | 142,333 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Orbimed Advisors | 10,039,691 | $313,740,000 | 3.45% |
| Baker Brothers Advisors | 10,123,824 | $316,370,000 | 1.39% |
| Logos Global Management LP | 400,000 | $12,500,000 | 0.90% |
| HHLR ADVISORS, LTD. | 583,333 | $18,229,000 | 0.24% |
| Rock Springs Capital Management LP | 362,359 | $11,324,000 | 0.24% |
| Virtus ETF Advisers LLC | 6,292 | $197,000 | 0.09% |
| FEDERATED HERMES, INC. | 408,100 | $12,753,000 | 0.02% |
| Virtu Financial LLC | 7,940 | $248,000 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 1,483,319 | $46,353,719,000 | 0.02% |
| FMR LLC | 7,055,666 | $220,489,000 | 0.02% |